BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30590942)

  • 1. Fatty pancreas disease: clinical impact.
    Blaho M; Dítě P; Kunovský L; Martínek A
    Vnitr Lek; 2018; 64(10):949-952. PubMed ID: 30590942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty pancreas disease.
    Alempijevic T; Dragasevic S; Zec S; Popovic D; Milosavljevic T
    Postgrad Med J; 2017 Apr; 93(1098):226-230. PubMed ID: 28069746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.
    Romana BS; Chela H; Dailey FE; Nassir F; Tahan V
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):547-554. PubMed ID: 29595117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Fatty Pancreas Disease: Clinical Consequences.
    Dite P; Blaho M; Bojkova M; Jabandziev P; Kunovsky L
    Dig Dis; 2020; 38(2):143-149. PubMed ID: 31865317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PANCREATIC STEATOSIS: A NEW DIAGNOSIS AND THERAPEUTIC CHALLENGE IN GASTROENTEROLOGY.
    Paul J; Shihaz AVH
    Arq Gastroenterol; 2020; 57(2):216-220. PubMed ID: 32490903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis.
    Bi Y; Wang JL; Li ML; Zhou J; Sun XL
    Diabetes Metab Res Rev; 2019 Jul; 35(5):e3142. PubMed ID: 30767421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease.
    Catanzaro R; Cuffari B; Italia A; Marotta F
    World J Gastroenterol; 2016 Sep; 22(34):7660-75. PubMed ID: 27678349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Alcoholic Fatty Pancreas Disease: The Unsung Disease.
    Sevim BC; Chela H; Ertugrul H; Malik LS; Malik S; Basar O; Daglilar E; Samiullah S; Gaballah AH; Tahan V
    Endocr Metab Immune Disord Drug Targets; 2023; 23(4):485-493. PubMed ID: 36177623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic steatosis and metabolic pancreatic disease: a new entity?
    Caldart F; de Pretis N; Luchini C; Ciccocioppo R; Frulloni L
    Intern Emerg Med; 2023 Nov; 18(8):2199-2208. PubMed ID: 37462859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic steatosis: Is it related to either obesity or diabetes mellitus?
    Pezzilli R; Calculli L
    World J Diabetes; 2014 Aug; 5(4):415-9. PubMed ID: 25126389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.
    Filippatos TD; Alexakis K; Mavrikaki V; Mikhailidis DP
    Dig Dis Sci; 2022 Jan; 67(1):26-41. PubMed ID: 33469809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Alcoholic Fatty Pancreatic Disease: A Review of Literature.
    Tariq H; Nayudu S; Akella S; Glandt M; Chilimuri S
    Gastroenterology Res; 2016 Dec; 9(6):87-91. PubMed ID: 28058076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Clinical Implications of Fatty Pancreas: A Concise Review.
    Khoury T; Asombang AW; Berzin TM; Cohen J; Pleskow DK; Mizrahi M
    Dig Dis Sci; 2017 Oct; 62(10):2658-2667. PubMed ID: 28791556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic Fatty Pancreas Disease.
    Shah N; Rocha JP; Bhutiani N; Endashaw O
    Nutr Clin Pract; 2019 Oct; 34 Suppl 1():S49-S56. PubMed ID: 31535735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty pancreas disease - practices for clinicians.
    Pinte L; Balaban DV; Băicuş C; Jinga M
    Rom J Intern Med; 2019 Sep; 57(3):209-219. PubMed ID: 30901317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between abdominal fat stores and liver fat, pancreatic fat, and metabolic comorbidities in a pediatric population with non-alcoholic fatty liver disease.
    Trout AT; Hunte DE; Mouzaki M; Xanthakos SA; Su W; Zhang B; Dillman JR
    Abdom Radiol (NY); 2019 Sep; 44(9):3107-3114. PubMed ID: 31312893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enlarged pancreas: not always a cancer.
    Calculli L; Festi D; Pezzilli R
    Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):107-8. PubMed ID: 25655299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothyroidism and subclinical hypothyroidism are associated with fatty pancreas (Non-Alcoholic Fatty Pancreas Disease).
    Bayyigit A; Gokden Y; Onol S; Ozek FZ; Saglam S; Adas M
    Diabetes Metab Res Rev; 2024 Feb; 40(2):e3720. PubMed ID: 37691570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipid accumulation in the pancreas: clinical significance of NAFPD (non-alcoholic fatty pancreas disease)].
    Jermendy G
    Orv Hetil; 2022 Oct; 163(44):1735-1742. PubMed ID: 36309887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty pancreas disease and pancreatic exocrine insufficiency: pilot study and systematic review.
    Maetzel H; Rutkowski W; Panic N; Mari A; Hedström A; Kulinski P; Stål P; Petersson S; Brismar TB; Löhr JM; Vujasinovic M
    Scand J Gastroenterol; 2023; 58(9):1030-1037. PubMed ID: 37088949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.